Recurrent dysphasia due to nivolumab-induced encephalopathy with presence of Hu autoantibody

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.5K citations · Full text

Life Sciences, Oncology, Pharmacotherapy +17

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Julie R. Brahmer, Karen L. Reckamp, Lucio Crinò et al. · New England Journal of Medicine · 2015 · 8.6K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Haidong Dong, Gefeng Zhu, Koji Tamada et al. · Nature Medicine · 1999 · 2.5K citations

Life Sciences, Cell Biology, Immunology +10

Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients

Francesc Graus · Brain · 2001 · 892 citations · Full text

Medicine, Neurology, Oncology +14

Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy

Lisa Zimmer, Simone M. Goldinger, Lars Hofmann et al. · European Journal of Cancer · 2016 · 560 citations

Medicine, Pharmacology, Pharmacotherapy +11